Literature DB >> 10578241

The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder.

D C Rowe1, E J Van den Oord, C Stever, L N Giedinghagen, J M Gard, H H Cleveland, M Gilson, S T Terris, J H Mohr, S Sherman, A Abramowitz, I D Waldman.   

Abstract

The relationship of the DRD2 TaqI-A1 allele to hyperactive/impulsive and inattentive symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents was examined in a sample of clinic-referred children and their siblings, and control children and their siblings (n = 236). The contribution of genetic dominance and additivity to mean differences among the A2A2, A1A2, and A1A1 genotypes was estimated using structural equation modeling. The effect of genetic additivity was statistically significant for both traits in an analysis of all children. The heritability from the DRD2 locus was estimated at 4.27% for hyperactive-impulsive symptoms and 2.12% for inattentive symptoms. Children with the A2A2 genotype had the highest mean level of symptoms. To control for any possible effects of population stratification, this analysis was repeated with parental genotypes as controls. In this smaller sample, although the direction of the effect was the same as that in the whole sample, the genotypic differences failed to reach conventional significance levels and the effect sizes were smaller (h2 = 1.62% and 0.79%, respectively). Furthermore, a genotype relative risk test of children who had questionnaire-based diagnoses of ADHD also failed to yield evidence of either association or linkage. Given that the A1 allele was expected to be the high risk allele, and that results were non-significant in tests that controlled for population heterogeneity, we doubt that this DRD2 polymorphism influences symptoms of ADHD in childhood.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10578241     DOI: 10.1038/sj.mp.4000567

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  12 in total

Review 1.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

Review 2.  Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?

Authors:  Mark S Gold; Kenneth Blum; Marlene Oscar-Berman; Eric R Braverman
Journal:  Postgrad Med       Date:  2014-01       Impact factor: 3.840

Review 3.  Dopamine genes and attention-deficit hyperactivity disorder: a review.

Authors:  Salvatore DiMaio; Nathalie Grizenko; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

Review 4.  Molecular genetics of attention deficit hyperactivity disorder.

Authors:  Stephen V Faraone; Eric Mick
Journal:  Psychiatr Clin North Am       Date:  2010-03

5.  An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood.

Authors:  Russell A Barkley; Karen M Smith; Mariellen Fischer; Bradford Navia
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-07-05       Impact factor: 3.568

Review 6.  Candidate gene studies of ADHD: a meta-analytic review.

Authors:  Ian R Gizer; Courtney Ficks; Irwin D Waldman
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

7.  Potential Role of Brain-Derived Neurotrophic Factor and Dopamine Receptor D2 Gene Variants as Modifiers for the Susceptibility and Clinical Course of Wilson's Disease.

Authors:  Shubhrajit Roy; Prosenjit Pal; Sampurna Ghosh; Sreyashi Bhattacharya; Shyamal Kumar Das; Prasanta Kumar Gangopadhyay; Ashish Bavdekar; Kunal Ray; Mainak Sengupta; Jharna Ray
Journal:  Neuromolecular Med       Date:  2018-07-10       Impact factor: 3.843

8.  The ANKK1 kinase gene and psychiatric disorders.

Authors:  Guillermo Ponce; Rocío Pérez-González; María Aragüés; Tomás Palomo; Roberto Rodríguez-Jiménez; Miguel Angel Jiménez-Arriero; Janet Hoenicka
Journal:  Neurotox Res       Date:  2009-04-07       Impact factor: 3.911

9.  Enrichment of putatively damaging rare variants in the DYX2 locus and the reading-related genes CCDC136 and FLNC.

Authors:  Andrew K Adams; Shelley D Smith; Dongnhu T Truong; Erik G Willcutt; Richard K Olson; John C DeFries; Bruce F Pennington; Jeffrey R Gruen
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

10.  Dopaminergic Modulation of Goal-Directed Behavior in a Rodent Model of Attention-Deficit/Hyperactivity Disorder.

Authors:  Joman Y Natsheh; Michael W Shiflett
Journal:  Front Integr Neurosci       Date:  2018-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.